Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)-Reference-Cited by-同舟云学术

Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)

Published:2004-11-08 Issue:3 Volume:24 Page:344-354
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Yin Dong,Zhou Hong,Kumagai Takashi,Liu Gentao,Ong John M,Black Keith L,Koeffler H Phillip

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/1208225.pdf

Reference34 articles.

1. Adams J, Palombella VJ and Elliott PJ . (2000). Invest. New Drugs, 18, 109–121.

2. Adams J, Palombella VJ, Sausville EA, Johnson J, Destree A, Lazarus DD, Maas J, Pien CS, Prakash S and Elliott PJ . (1999). Cancer Res., 59, 2615–2622.

3. An J, Sun YP, Adams J, Fisher M, Belldegrun A and Rettig MB . (2003). Clin. Cancer Res., 9, 4537–4545.

4. Cusack JCJ, Liu R, Houston M, Abendroth K, Elliott PJ, Adams J and Baldwin ASJ . (2001). Cancer Res., 61, 3535–3540.

5. Dai Y, Rahmani M and Grant S . (2003). Oncogene, 22, 7108–7122.

Cited by 204 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic insights and the clinical prospects of targeted therapies for glioblastoma: a comprehensive review;Experimental Hematology & Oncology;2024-04-13

2. Proteasome Inhibitors against Glioblastoma—Overview of Molecular Mechanisms of Cytotoxicity, Progress in Clinical Trials, and Perspective for Use in Personalized Medicine;Current Oncology;2023-11-02

3. SEM1 promotes tumor progression of glioblastoma via activating the akt signaling pathway;Cancer Letters;2023-11

4. Bortezomib Is Effective in the Treatment of T Lymphoblastic Leukaemia by Inducing DNA Damage, WEE1 Downregulation, and Mitotic Catastrophe;International Journal of Molecular Sciences;2023-09-27

5. Novel sights on therapeutic, prognostic, and diagnostics aspects of non-coding RNAs in glioblastoma multiforme;Metabolic Brain Disease;2023-05-30